FDA clears Roche and Eli Lilly's Alzheimer's blood test for primary and specialty care
What happened
The Elecsys pTau217 test can help doctors assess amyloid pathology in people 55 and older showing signs of cognitive decline
Summary assembled by rule from the sources below
Timeline
- First appeared on QuartzQuartz